Interactive voice response (IVR) for tobacco cessation: a systematic review.

health services preventive medicine public health

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
09 Jul 2024
Historique:
medline: 11 7 2024
pubmed: 11 7 2024
entrez: 10 7 2024
Statut: epublish

Résumé

To summarise the uses, outcomes and implementation of interactive voice response (IVR) as a tobacco cessation intervention. A systematic review was conducted. Searches were performed on 3 May 2023. The strategies used keywords such as "tobacco cessation", "smoking reduction" and "interactive voice recording". Ovid MEDLINE ALL, Embase, APA PsycINFO, CINAHL, Cochrane Library and Web of Science were searched. Grey literature searches were also conducted. Titles and abstracts were assessed by two independent reviewers. Studies were included if IVR was an intervention for tobacco cessation for adults; any outcomes were reported and study design was comparative. Any abstract included by either reviewer proceeded to full-text review. Full texts were reviewed by two independent reviewers. Data were independently extracted by two reviewers using a standardised form. The Risk of Bias Tool for Randomised Trials and the Risk of Bias in Non-Randomised Studies of Interventions tools were used to assess study quality. Of 308 identified abstracts, 20 moderate-quality to low-quality studies were included. IVR was used standalone or adjunctly as a treatment, follow-up or risk-assessment tool across populations including general smokers, hospitalised patients, quitline users, perinatal women, patients with cancer and veteran smokers. Effective studies found that IVR was delivered more frequently with shorter follow-up times. Significant gaps in the literature include a lack of population diversity, limited implementation settings and delivery schedules, and limited patient and provider perspectives. While the evidence is weak, IVR appears to be a promising intervention for tobacco cessation. However, pilot programmes and research addressing literature gaps are necessary.

Identifiants

pubmed: 38986561
pii: bmjopen-2023-081972
doi: 10.1136/bmjopen-2023-081972
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e081972

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Maha Khan (M)

Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Ally Memedovich (A)

Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Nkiruka Eze (N)

Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Benedicta Asante (B)

Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Kamala Adhikari (K)

Provincial Population and Public Health, Holy Cross Centre, Alberta Health Services, Calgary, Alberta, Canada.

Rachel Dunn (R)

Provincial Population and Public Health, Holy Cross Centre, Alberta Health Services, Calgary, Alberta, Canada.

Fiona Clement (F)

Community Health Sciences, University of Calgary, Calgary, Alberta, Canada fclement@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH